Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-13-001446
Filing Date
2013-03-29
Accepted
2013-03-29 16:59:19
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K elgo_10k.htm 10-K 1029185
2 CERTIFICATION elgo_ex311.htm EX-31.1 14518
3 CERTIFICATION elgo_ex312.htm EX-31.2 14397
4 CERTIFICATION elgo_ex321.htm EX-32.1 6178
5 CERTIFICATION elgo_ex322.htm EX-32.2 6233
12 img001.jpg GRAPHIC 13444
  Complete submission text file 0001477932-13-001446.txt   2963159

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT elgo-20121231.xml EX-101.INS 230657
7 XBRL TAXONOMY EXTENSION SCHEMA elgo-20121231.xsd EX-101.SCH 28755
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elgo-20121231_cal.xml EX-101.CAL 36040
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elgo-20121231_def.xml EX-101.DEF 33166
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE elgo-20121231_lab.xml EX-101.LAB 174832
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elgo-20121231_pre.xml EX-101.PRE 119819
Mailing Address 1264 UNIVERSITY AVENUE WEST SUITE 404 ST. PAUL MN 55104
Business Address 1264 UNIVERSITY AVENUE WEST SUITE 404 ST. PAUL MN 55104 5163038181
Enterologics, Inc. (Filer) CIK: 0001483731 (see all company filings)

EIN.: 800504940 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54347 | Film No.: 13728219
SIC: 2834 Pharmaceutical Preparations